Patient P-02308
Synthetic patientMETA-24 · Day 157 · 35–44 · F · baseline S13Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
35%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S13
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 108 BR-03 recommended — Behavioural Recommendation BR-03
- Day 109 Patient accepted — Started BR-03 in the companion
- Day 116 No meaningful change — Behavioural Recommendation BR-03
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- Inflammatory activity+15
- GI instability+12
- Nutritional resilience-6
- Treatment adherence-6
- Toxicity+3
What helped?
- Behavioural Recommendation BR-03Day 108Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable68 min
stable · +1.6 vs previous 14 d
Sleep duration
Wearable6.9 h
stable · +0.0 vs previous 14 d
Energy level
Daily log5.1/10
worsening · -0.2 vs previous 14 d
Steps
Wearable6,666
worsening · -337 vs previous 14 d
GI burden
Companion25.6/100
improving · -1.3 vs previous 14 d
Adherence
Companion84.4 %
worsening · -4.7 vs previous 14 d
Sleep quality
Wearable49.1/100
improving · +2.8 vs previous 14 d
Glucose, CGM daily mean
CGM132 mg/dL
stable · -1.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 53 from the failing basin, 53 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -4.8 next day on high-intake days · n 21
- More simple carbsGI -2.4 next day on high-intake days · n 25
Would not help
- BR-03 Behavioural Recommendationalready tried, no meaningful change
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.8supporter · 95%
- Simple carbohydrates-2.4supporter · 55%
- Insoluble fibre+2.4no signal · 54%
- Dietary fat load-1.1no signal · 16%
- Alcohol-1.1no signal · 26%
- Histamine load+0.5no signal · 15%
- Caffeine+0.4no signal · 15%
- Ultra-processed food-0.4no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓25
- WearableResting HR 77 bpm
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.8 · butyrate capacity 55/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 57 ms
- Sleep
- 7.2 h
- Steps
- 6,506
- Resting HR
- 74 bpm
Daily log: GI score 26, nutritional resilience 57, adherence 84.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02093 | 44% | S05 | AD-05 | no change | 40 |
| P-02285 | 37% | S14 | AD-05 | no change | 39 |
| P-02031 | 33% | S12 | AD-05 | improved | 47 |
| P-02552 | 32% | S07 | AD-05 | no change | 29 |
| P-02087 | 44% | S01 | BR-03 | no change | 40 |
| P-02522 | 39% | S01 | BR-03 | no change | 40 |
| P-02439 | 38% | S08 | BR-03 | no change | 40 |
| P-02325 | 35% | S19 | BR-03 | no change | 33 |
| P-02638 | 34% | S01 | BR-03 | improved | 41 |
| P-02564 | 33% | S15 | BR-03 | improved | 32 |
| P-02267 | 31% | S09 | BR-03 | no change | 45 |
| P-02331 | 31% | S14 | BR-03 | improved | 34 |